| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/27/2005 | US20050019759 Attenuated HIV strains and uses thereof |
| 01/27/2005 | US20050019754 Peptides of given sequence with immunogenic epitopes activating CD8+ class I major histocompatibility complex restricted cytotoxic T-lymphocytes for patients harboring latent HCMV infection in the absence of active viral replication; using enriched antigen presenting cells; vaccines |
| 01/27/2005 | US20050019752 Novel chimeric rev, tat, and nef antigens |
| 01/27/2005 | US20050019751 Contacting human scavenger receptor class B type I with polypeptide and measuring ability of test compound to inhibit binding; used in treatment and prophylaxis |
| 01/27/2005 | US20050019749 Molecular vector for the genophenotypic characterisation of v3 sequences of hiv-1 gp120 and process for preparation thereof |
| 01/27/2005 | US20050019417 stabilization of proteins, peptides or cells by fluidization of microparticles to form fluidized bed of microparticles comprising water soluble gel forming solid particles, then spraying coating with liquids comprising sugars and solvents, and drying |
| 01/27/2005 | US20050019346 Nucleic acids and regulatory sequences; gene expression; antitumor agents |
| 01/27/2005 | US20050019345 Collagen-binding proteins from Streptococcus pyogenes |
| 01/27/2005 | US20050019344 Antigens; vaccines; isolated peptide |
| 01/27/2005 | US20050019343 administering an effective dose of a polypeptide comprising an immunogenic fragment of A beta (SEQ ID NO:1) and an adjuvant in a regime effective to induce an immune response comprising antibodies to the A beta fragment; Alzheimer's disease |
| 01/27/2005 | US20050019341 Gene that codes tumor antigen is detected by cytotoxic lymphocyte; isolated from Dna libraries |
| 01/27/2005 | US20050019335 Attenuated mutant Salmonella bacteria containing deactivated gene used as vaccine |
| 01/27/2005 | US20050019334 Interleukin antibody or fusion protein; comprising active material and FC domain; Escherichia coli cells |
| 01/27/2005 | US20050019333 Glycosylated specificity exchangers |
| 01/27/2005 | US20050019331 Moderate neutrophilsin wound area; antiinflammatory agents; wound healing agents |
| 01/27/2005 | US20050019330 administering an antibody that specifically binds to the amyloid deposit or a component thereof; can be a human, humanized, chimeric or nonhuman antibody and can be monoclonal or polyclonal; also a novel monoclonal antibody which specifically binds to an epitope within residues 13-28 of A beta |
| 01/27/2005 | US20050019328 Prevention and treatment of amyloidogenic disease |
| 01/27/2005 | US20050019325 WSX receptor agonist antibodies |
| 01/27/2005 | US20050019324 Peptides and antibodies to muc 1 proteins |
| 01/27/2005 | US20050019306 Hybrid fusion protein transcription regulator to induce interferon target gene expression |
| 01/27/2005 | US20050019304 Novel human mage-like protein |
| 01/27/2005 | US20050019297 Protein derived composition for skin care using spider silk protein or an analog with adjuvants |
| 01/27/2005 | US20050019263 Conjugate for differentiating between healthy and unhealthy tissue |
| 01/27/2005 | US20050019261 Using serine protease inhibitor; contacting brain tissue; analyzing in variations in protease gene expression |
| 01/27/2005 | US20050019260 Animal model for allergy |
| 01/27/2005 | US20050016676 Method and kit providing bioadhesive binding or coating with polyphenolic mussel proteins |
| 01/27/2005 | DE10328067A1 Isoliertes Photoprotein Bolinopsin, sowie dessen Verwendung The isolated photoprotein Bolinopsin, and its use |
| 01/27/2005 | CA2805464A1 Human antibody molecules for il-13 |
| 01/27/2005 | CA2537896A1 East coast fever vaccine based on ctl-specific schizont antigens |
| 01/27/2005 | CA2534027A1 Variants of human taste receptor genes |
| 01/27/2005 | CA2533522A1 Amino acid-substituted coagulation factor v |
| 01/27/2005 | CA2532630A1 Use of lymphocytes transformed with .alpha.-2-heremans-schmid glycoprotein (ahsg) to treat tgf-.beta.-mediated cancer |
| 01/27/2005 | CA2532186A1 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 01/27/2005 | CA2532164A1 Subunit vaccine against respiratory syncytial virus infection |
| 01/27/2005 | CA2532138A1 Injection of bone marrow-derived cells and medium for angiogenesis |
| 01/27/2005 | CA2532127A1 Regulatory t-cells containing galectins for the therapy and diagnosis of diseases |
| 01/27/2005 | CA2531393A1 Recombinant expression of streptococcus pyogenes cysteine protease and immunogenic compositions thereof |
| 01/26/2005 | EP1500704A1 Expression system of actinomycete-origin cytochrome p-450 in escherichia coli |
| 01/26/2005 | EP1500703A2 Human gaba receptors and polynucleotides encoding the same |
| 01/26/2005 | EP1500702A1 APO-2LI and APO-3 apoptosis polypeptides from the TNFR1 familiy |
| 01/26/2005 | EP1500701A1 Cancer-associated gene mina 53, protein mina 53 and monoclonal antibody thereof |
| 01/26/2005 | EP1500698A1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport |
| 01/26/2005 | EP1500664A1 Gelatin derivatives and high-molecular micelles comprising the same |
| 01/26/2005 | EP1500663A1 Secreted proteins and their uses |
| 01/26/2005 | EP1500662A2 Stabilizing peptides |
| 01/26/2005 | EP1500661A1 Separation of protein monomers from aggregates by use of ion-exchange chromatography |
| 01/26/2005 | EP1500399A1 Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative deseases |
| 01/26/2005 | EP1500329A2 Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
| 01/26/2005 | EP1499888A2 Conformationally constrained peptides that bind the orl-1 receptor |
| 01/26/2005 | EP1499886A1 Methods and compositions for inducing an immune response |
| 01/26/2005 | EP1499748A1 Hepatitis c virus assay systems |
| 01/26/2005 | EP1499736A1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 01/26/2005 | EP1499735A2 Optimization of transgene expression in mammalian cells |
| 01/26/2005 | EP1499732A2 Essential and important genes of pseudomonas aeroginosa and the use thereof to design or identify antibacterial agents |
| 01/26/2005 | EP1499731A2 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
| 01/26/2005 | EP1499730A1 Immunoconjugates for the treatment of tumours |
| 01/26/2005 | EP1499729A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
| 01/26/2005 | EP1499727A1 Hepatitis c virus replicon containing a reporter gene and a selectable marker gene |
| 01/26/2005 | EP1499726A1 Chimeric camp factors for vaccination against streptococcus infection |
| 01/26/2005 | EP1499725A1 Psp94 binding protein and psp94 diagnostic assays |
| 01/26/2005 | EP1499724A1 Derivatives of the il-2 receptor gamma chain, their production and use |
| 01/26/2005 | EP1499719A1 FACTOR VII OR VIIa POLYPEPTIDE VARIANTS |
| 01/26/2005 | EP1499713A2 Genomic library of cyanophage s-2l and functional analysis |
| 01/26/2005 | EP1499712A1 Hepatitis b viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
| 01/26/2005 | EP1499640A2 Immunoglobulin-domain containing cell surface recognition molecules |
| 01/26/2005 | EP1499639A1 Novel nucleic acid sequences and proteins of tumors and neoplasias of the thyroid gland |
| 01/26/2005 | EP1499638A2 Height-related gene |
| 01/26/2005 | EP1499637A1 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same |
| 01/26/2005 | EP1499636A2 Neurotrophic and neuroprotective peptides |
| 01/26/2005 | EP1499635A2 Teneurin c-terminal associated peptides (tcap) and uses thereof |
| 01/26/2005 | EP1499634A2 COMBINATION VACCINES INCLUDING IMMUNOGENIC GapC AND CAMP FACTOR POLYPEPTIDES |
| 01/26/2005 | EP1499633A2 Hagfish cathelin-associated antimicrobial peptides and genes |
| 01/26/2005 | EP1499630A2 Streptavidin expressed gene fusions and methods of use thereof |
| 01/26/2005 | EP1499362A1 Fusions of cytokines and tumor targeting proteins |
| 01/26/2005 | EP1499355A2 Use of parapox b2l protein to treat cancer and modify immune responses |
| 01/26/2005 | EP1499352A1 Recombinant anti-interleukin-9 antibodies |
| 01/26/2005 | EP1499351A2 Antibodies that specifically bind to tr2 |
| 01/26/2005 | EP1499350A2 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 01/26/2005 | EP1499349A2 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 01/26/2005 | EP1499348A2 Multi plasmid system for the production of influenza virus |
| 01/26/2005 | EP1499346A2 Treatment of type 1 diabetes before and after expression of predisposition markers |
| 01/26/2005 | EP1499339A1 Anti-inflammatory and wound healing effects of lymphoid thymosin beta 4 |
| 01/26/2005 | EP1499337A1 Immunotherapeutic and immunoprophylactic reagents |
| 01/26/2005 | EP1499327A2 Beta -amyloid peptide-binding proteins and polynucleotides encoding the same |
| 01/26/2005 | EP1499292A1 In vivo imaging of apoptosis |
| 01/26/2005 | EP1499182A1 Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression |
| 01/26/2005 | EP1499181A2 Vascularized human skin equivalent |
| 01/26/2005 | EP1499180A2 Cancer models |
| 01/26/2005 | EP1499176A2 Novel vip3 toxins and methods of use |
| 01/26/2005 | EP1499175A2 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 01/26/2005 | EP1451309A4 Love variant regulator molecules |
| 01/26/2005 | EP1440151A4 Seed specific 7s alpha promoter for expressing genes in plants |
| 01/26/2005 | EP1438331A4 A novel modulator of non-genonic activity of nuclear receptors (mnar) and uses thereof |
| 01/26/2005 | EP1417344A4 Zinc finger domain libraries |
| 01/26/2005 | EP1385881A4 Anti-obesity polypeptides |
| 01/26/2005 | EP1383889A4 Modified organs and cells for xenotransplantation |
| 01/26/2005 | EP1315794A4 Genetic demonstration of requirement for nkx6.1, nkx2.2 and nkx6.2 in ventral neuron generation |
| 01/26/2005 | EP1294921A4 Transgenically produced platelet derived growth factor |
| 01/26/2005 | EP1280901B1 3d structure of polypeptides containing a tpr-structure motif with chaperone-binding function, crystals thereof and compounds for inhibition of said peptides |
| 01/26/2005 | EP1257167A4 Production of mammals which produce progeny of a single sex |